Susanne Klutmann

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Andreas Engert, Heinz Haverkamp, Carsten Kobe et al. · The Lancet · 2012 · 632 citations

Medicine, Oncology, Radiation Oncology +15

Feasibility of ¹⁸F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic Plaque

Thorsten Derlin, Ulrich Richter, Peter Bannas et al. · Journal of Nuclear Medicine · 2010 · 257 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts

Johannes Keller, Philip Catalá-Lehnen, Antje K. Huebner et al. · Nature Communications · 2014 · 209 citations · Full text

Medicine, Cell Biology, Molecular Biology +17

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Carsten Kobe, Markus Dietlein, Jeremy Franklin et al. · Blood · 2008 · 204 citations · Full text

Medicine, Oncology, Radiology +17

FDG PET detection of unknown primary tumors.

K. H. Bohuslavizki, Susanne Klutmann, Sabine Kröger et al. · PubMed · 2000 · 192 citations

Medicine, Oncology, Radiology +17